Statistics

Total Visits

Views
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study(legacy) 125
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study(legacy) 85

Total Visits per Month

September 2023 October 2023 November 2023 December 2023 January 2024 February 2024 March 2024
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study 4 1 4 0 4 3 4

File Downloads

Views

Top Country Views

Views
United States 85
Australia 37
China 14
Netherlands 8
France 7
Vietnam 6
Germany 2
Ireland 1
Sweden 1

Top City Views

Views
Ashburn 37
Kaleen 31
Fairfield 12
Rotterdam 8
Hanoi 6
Zhengzhou 5
Beijing 3
Cambridge 3
New York 2
San Ramon 2